AAAAAA

   
Results: 1-2 |
Results: 2
THE INCIDENCE OF THROMBOTIC AND EMBOLIC EVENTS IN CONTROLLED CLINICAL-TRIALS OF BREAST-CANCER (CA) PATIENTS (PTS) UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITH THE STAMP-I REGIMEN AND AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION
Authors: VREDENBURGH J GLASPY J BOLWELL B DEMETRI GD KIN B JELACAMAXWELL K SHPALL EJ
Citation: J. Vredenburgh et al., THE INCIDENCE OF THROMBOTIC AND EMBOLIC EVENTS IN CONTROLLED CLINICAL-TRIALS OF BREAST-CANCER (CA) PATIENTS (PTS) UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITH THE STAMP-I REGIMEN AND AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION, Blood, 90(10), 1997, pp. 972-972
RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR AND FILGRASTIM FOR PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA PATIENTS - RESULTS OF A PHASE I II TRIAL/
Authors: MOSKOWITZ CH STIFF P GORDON MS MCNIECE I HO AD COSTA JJ BROUN ER BAYER RA WYRES M HILL J JELACAMAXWELL K NICHOLS CR BROWN SL NIMER SD GABRILOVE J
Citation: Ch. Moskowitz et al., RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR AND FILGRASTIM FOR PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA PATIENTS - RESULTS OF A PHASE I II TRIAL/, Blood, 89(9), 1997, pp. 3136-3147
Risultati: 1-2 |